Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Castro

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
AIDS and Behavior|July 31, 2021
Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral TreatmentMargaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, et al.
Journal of Neuro-Oncology|June 8, 2021
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefitMichael Castro, Anusha Pampana, Aftab Alam, et al.
Clinical Lung Cancer|April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint InhibitorsMark Klein, Drew Watson, Michael Castro, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
Nature Communications|August 10, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccinePauline Latzer, Henning Zelba, Florian Battke, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
AIDS and Behavior|July 31, 2021
Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral TreatmentMargaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, et al.
Journal of Neuro-Oncology|June 8, 2021
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefitMichael Castro, Anusha Pampana, Aftab Alam, et al.
Clinical Lung Cancer|April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint InhibitorsMark Klein, Drew Watson, Michael Castro, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
Nature Communications|August 10, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccinePauline Latzer, Henning Zelba, Florian Battke, et al.
Pageof 3